©Author(s) (or their employer(s)) 2026.
World J Gastrointest Surg. Feb 27, 2026; 18(2): 114607
Published online Feb 27, 2026. doi: 10.4240/wjgs.v18.i2.114607
Published online Feb 27, 2026. doi: 10.4240/wjgs.v18.i2.114607
Table 3 Comparison of treatment completion between groups, n (%)/mean ± SD
| Item | Nutritional risk group (n = 37) | Non-nutritional risk group (n = 43) | χ²/t | P value |
| Completed all planned cycles | 28 (75.7) | 41 (95.3) | 6.859 | 0.009 |
| RDI (%) | 78.6 ± 14.2 | 92.1 ± 8.7 | -5.142 | < 0.001 |
| RDI grouping | ||||
| ≥ 85% | 18 (48.6) | 38 (88.4) | 15.671 | < 0.001 |
| < 85% | 19 (51.4) | 5 (11.6) | ||
| Actual completion cycle proportion | ||||
| 100% | 28 (75.7) | 41 (95.3) | 8.762 | 0.013 |
| 80%-99% | 6 (16.2) | 2 (4.7) | ||
| < 80% | 3 (8.1) | 0 (0) | ||
| Treatment adjustment | ||||
| Dose reduction | 15 (40.5) | 7 (16.3) | 6.025 | 0.014 |
| Treatment delay | 18 (48.6) | 9 (20.9) | 6.896 | 0.009 |
| Early termination | 9 (24.3) | 2 (4.7) | 6.859 | 0.009 |
- Citation: Zhou K, Tu RF, Lu LH, Zhang H. Impact of nutritional status on treatment completion and prognosis during adjuvant chemotherapy following gastric cancer surgery. World J Gastrointest Surg 2026; 18(2): 114607
- URL: https://www.wjgnet.com/1948-9366/full/v18/i2/114607.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v18.i2.114607